
Stony Brook tests experimental breast cancer vaccine to cut recurrence risk
A breast cancer survivor at Stony Brook University Hospital participates in a global clinical trial of an experimental tumor vaccine aimed at reducing recurrence risk, reflecting ongoing efforts to improve prevention after initial treatment.




